Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer

NCT05173103 · clinicaltrials.gov ↗

COMPLETED

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer
Hormone Receptor Positive Breast Carcinoma
HER2-negative Breast Cancer

Sponsor

University of Milano Bicocca